Verrucous psoriasis (VP)
is a rare variant of psoriasis with wart-like changes clinically and
histologically. It is characterized by symmetric hypertrophic verrucous plaques
that may have an erythematous base and involve the legs, arms, trunk, and
dorsal aspect of the hands [1]. Cutaneous horn is a conical markedly
hyperkeratotic excrescence or overgrowth of epidermis that is usually seen in
squamous cell carcinoma, basal cell epithelioma, nevoid conditions, wart, and
keratoacanthoma. They are usually solitary and frequently associated with
malignant change of the underlying epidermis [2]. To our best knowledge, there
have been just 2 case reports of verrucous psoriasis presenting as multiple
cutaneous horns to date.
Histologically, VP is
characterised by overlapping features of verruca vulgaris and psoriasis. A
large histopathologic study of 12 cases of VP reported regular psoriasiform
epidermal hyperplasia with acanthosis, hyperkeratosis, and neutrophil
collections in the stratum corneum (Munro microabscesses) or stratum spinosum
(spongiform pustules of Kogoj) [1]. In addition, they reported papillomatosis
with bowing of the peripheral rete ridges toward the centre of the lesion (buttressing).
These findings are highly suggestive of verrucous psoriasis. These changes were
noted in our case too. Hypergranulosis and koilocytic change, typical of
verruca vulgaris, are usually not observed.
The etiology of this
entity is unknown. Others have reported repeated trauma as contributing to the
pathogenesis [3]. In our patient, there was no history of trauma but intake of
a combination of homeopathic drugs for a long duration may have precipitated his
condition.
Verrucous psoriasis can
be recalcitrant to therapy. Although there are no studies addressing treatment
modalities, several recommendations can be derived from individual case
reports. The use of topical therapies, including topical corticosteroids,
keratolytic agents and calcipotriene, provide only minimal improvement when
used as monotherapy [3]. There have been successful reports of management of VP
with systemic therapies like methotrexate and acitretin [4,5]. Of particular
significance was a case report using a combination of acitretin with
methotrexate for successful clearance of a case of VP [5]. In view of the
extremely hyperkeratotic nature of the lesions and their high number in our
patient, we chose to go with this combination. This combination has
traditionally been avoided because of the risk for hepatotoxicity. However, a
case series has demonstrated a moderate safety profile with concurrent use of
these drugs in treatment-resistant psoriasis [6]. Our patient showed a
tremendous clinical response with this combination with most lesions flattening
out over a 6 month period. No side effects have been noted till date and the
patient continues to be in treatment with regular follow up.